ESTRO 2023 - Abstract Book

S455

Sunday 14 May 2023

ESTRO 2023

Blood in urine Urinary urgency

n=66 (96%) n=42 (61%) n=56 (81%)

n=0 (0%)

n= 14 (20%)

Urinary incontinence

n=5 (7%)

Achieve and maintain erection n=47 (68%)

n=17 (25%) n=18 (26%)

Ejaculation

n= 46 (67%)

Conclusion Our study is, to date, the largest patient reported outcomes study post MRI guided daily adaptive prostate SABR. It shows acceptable levels of toxicity up to 34 months post treatment PD-0574 Acute toxicity comparison of MR-guided adaptive versus CT-guided prostate SBRT: A meta-analysis J. Leeman 1 , K. Shin 2 , Y. Chen 2 , R. Mak 3 , P. Nguyen 3 , A. D'Amico 3 , N. Martin 3 1 Brigham and Women's Hospital/Dana-Farber Cancer Institute, Radiation Oncology, Boston, USA; 2 Dana Farber Cancer Institute, Data Sciences, Boston, USA; 3 Brigham and Women's Hospital/Dana Farber Cancer Institute, Radiation Oncology, Boston, USA